Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2024
A Goldilocks Computational Protocol for Inhibitor Discovery Targeting DNA Damage Responses Including Replication-Repair Functions, Davide Moiani and John A Tainer
Post-immunotherapy Ctla-4 IG Treatment Improves Antitumor Efficacy, Stephen Mok, Didem Ağaç Çobanoğlu, Huey Liu, et al.
Perioperative Chemoimmunotherapy Induces Strong Immune Responses and Long-Term Survival in Patients With Hla Class I-deficient Non-small Cell Lung Cancer, Marta Molina-Alejandre, Francisco Perea, Virginia Calvo, et al.
Unlocking Intracellular Oncology Targets: The Unique Role of Antibody-Based T-Cell Receptor Mimic (TCRm) Therapeutics in T-Cell Engagers (TCEs) and Antibody-Drug Conjugates (ADCs), Jeffrey Molldrem and Dongxing Zha
Differentiation Between Descending Thoracic Aortic Diseases Using Machine Learning and Plasma Proteomic Signatures, Amanda Momenzadeh, Simion Kreimer, Dongchuan Guo, et al.
The Fletcher-Cox Pathway: A Unique View on Clinical Trial Education, Shalini Moningi, Shane Stecklein, Sonal Noticewala, et al.
Targeting MCL1-Driven Anti-apoptotic Pathways Overcomes Blast Progression After Hypomethylating Agent Failure in Chronic Myelomonocytic Leukemia, Guillermo Montalban-Bravo, Natthakan Thongon, Juan Jose Rodriguez-Sevilla, et al.
Prognostic Scores for Ursodeoxycholic Acid-Treated Patients Predict Graft Loss and Mortality in Recurrent Primary Biliary Cholangitis After Liver Transplantation, Aldo J Montano-Loza, Ellina Lytvyak, Gideon Hirschfield, et al.
Differentiation Syndrome Associated With Treatment With IDH2 Inhibitor Enasidenib: Pooled Analysis From Clinical Trials, Pau Montesinos, Amir T Fathi, Stéphane de Botton, et al.
Influence of TP53 Gene Mutations and Their Allelic Status in Myelodysplastic Syndromes With Isolated 5q Deletion, Maria Julia Montoro, Laura Palomo, Claudia Haferlach, et al.
Harnessing Endoscopic Ultrasound-Guided Radiofrequency Ablation to Reshape the Pancreatic Ductal Adenocarcinoma Microenvironment and Elicit Systemic Immunomodulation, Vishali Moond, Bhumi Maniyar, Prateek Suresh Harne, et al.
Biological and Procedural Predictors of Outcome in the Stroke Preclinical Assessment Network (SPAN) Trial, Andreia Morais, Takahiko Imai, Xuyan Jin, et al.
Comparative Toxicological Assessment of 2 Bisphenols Using a Systems Approach: Evaluation of the Behavioral and Transcriptomic Responses of Danio rerio to Bisphenol A and Tetrabromobisphenol A, Michael G Morash, Morgan W Kirzinger, John C Achenbach, et al.
Toward Clinical-Grade Evaluation of Large Language Models, Amy C Moreno and Danielle S Bitterman
Transcriptomics Analysis Reveals Potential Mechanisms Underlying Mitochondrial Dysfunction and T Cell Exhaustion in Astronauts’ Blood Cells in Space, Maria Moreno-Villanueva, Luis E Jimenez-Chavez, Stephanie Krieger, et al.
Global Statement Defining Interventional Radiology-Have We Reached the Tipping Point?, Robert A Morgan, Parag J Patel, Christoph Binkert, et al.
Phospholipid Metabolic Adaptation Promotes Survival of IDH2 Mutant Acute Myeloid Leukemia Cells, Tatsuya Morishima, Koichi Takahashi, Desmond Wai Loon Chin, et al.
Additional Expression of T-cell Engager in Clinically Tested Oncolytic Adeno-Immunotherapy Redirects Tumor-Infiltrated, Irrelevant T Cells Against Cancer Cells to Enhance Antitumor Immunity, Daisuke Morita, Amanda Rosewell Shaw, Greyson Biegert, et al.
FC Gamma Receptors Promote Antibody-Induced LILRB4 Internalization and Immune Regulation of Monocytic AML, Joshua W Morse, Xun Gui, Mi Deng, et al.
Efficacy of Single-Agent Chemotherapy in Endocrine Therapy-Refractory Metastatic Invasive Lobular Carcinoma, Jason A Mouabbi, Wei Qaio, Yu Shen, et al.
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy, Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, et al.
Antiangiogenic Therapy Combined With Immune Checkpoint Blockade in Urothelial Cancer: Systematic Review and Meta-Analysis, Mohammad Jad Moussa, Iuliia Kovalenko, Emanuele Crupi, et al.
IRX4204 Induces Senescence and Cell Death in HER2-Positive Breast Cancer and Synergizes With Anti-HER2 Therapy, Cassandra L Moyer, Amanda Lanier, Jing Qian, et al.
Risk-Benefit Trade-Offs and Precision Utilities in Phase I-II Clinical Trials, Pavlos Msaouel, Juhee Lee, and Peter F Thall
Locoregional Therapies in Immunologically "Cold" Tumors: Opportunities and Clinical Trial Design Considerations, Pavlos Msaouel and Rahul A Sheth